RYTHM (RYM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
7 Nov, 2025Executive summary
Revenue for Q3 2025 was $4.0 million, up from zero in Q3 2024 and nearly double the prior quarter, driven by acquisitions, new brand launches, and expansion in hemp-derived THC beverages.
Net loss from continuing operations was $10.6 million for Q3 2025, compared to $16.4 million in Q3 2024; operating loss was $8.9 million, and net loss per share was $(5.33).
Discontinued operations (Cultivation and Extraction) resulted in a net gain of $1.5 million for the nine months ended September 30, 2025, due to a $3.5 million gain on disposal.
The company completed major strategic shifts, exiting Cultivation and Extraction to focus on branded hemp-derived products and licensing, and changed its name to RYTHM, Inc.
Cash and cash equivalents were $35.6 million as of September 30, 2025.
Financial highlights
Gross profit for Q3 2025 was $1.4 million (34% margin), up from $0.7 million in the previous quarter; for the nine months, $2.1 million (32.4% margin).
SG&A/operating expenses rose to $10.3 million in Q3 2025, up from $1.2 million in Q3 2024 and $7.5 million in the prior quarter, mainly due to sales and marketing for new product lines.
Interest expense increased to $1.1 million in Q3 2025, reflecting higher debt levels from new convertible notes.
Net cash used in operating activities was $20.5 million for the nine months ended September 30, 2025.
Basic and diluted net loss per share was $5.33 for Q3 2025.
Outlook and guidance
Management is focused on expanding distribution of hemp-derived beverages and edibles, with plans for further market expansion and increased brand visibility, especially for Señorita and RYTHM beverages.
The company may seek additional debt or equity financing to support growth, but future access to capital is not guaranteed.
Management anticipates continued growth in THC beverage demand, especially among younger consumers, and expects to capitalize on both licensing and direct sales revenue streams.
Latest events from RYTHM
- Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and equity plan amendment.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and equity plan expansion.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and major equity plan amendments.RYM
Proxy Filing1 Dec 2025 - Quorum for the August 2024 Annual Meeting is now one-third of outstanding shares.RYM
Proxy Filing1 Dec 2025 - Equity line offering seeks up to $15M amid financial challenges and industry risks.RYM
Registration Filing29 Nov 2025 - Registering 4.7M shares for resale to raise up to $15M amid ongoing losses and dilution risk.RYM
Registration Filing28 Nov 2025